Livita Life Sciences’ NanoBioglass represents a significant morphological advancement in biomaterials for bone tissue repair and injury treatment in Orthopedics and Dentistry Segments. By applying nanotechnology to Bioglass production, Livita Life Sciences, in collaboration with its associated researchers, has achieved an approximately 99% reduction in particle size compared to leading market competitors. This reduction directly influences the cascade of biological processes involved in bone regeneration. Perfectly spherical nanoparticles exhibit a higher surface area, facilitating more rapid and controlled dissolution, as well as the efficient release of calcium and phosphorus ions.These conditions promote the formation of hydroxyapatite, a key component in the osseointegration process.
Research Activities:
Development of bioactive glass nanoparticles (BGNs) for bone regeneration and localized drug delivery. Activities include controlled synthesis and functionalization of mesoporous nanoparticles to promote hydroxyapatite formation, enhance osteogenesis, and enable loading and controlled release of chemotherapeutic agents for bone cancer treatment. Research also involves incorporation into scaffolds or injectable systems and physicochemical and biological characterization for translational applications.
Aclid is the leading compliance automation platform for biosecurity and biosafety, supporting responsible innovation in the life sciences. Leading research institutions use Aclid’s unified platform for managing biosecurity, biosafety, quality, permitting, lab operations, and EHS.
Crowell Life Sciences, distinguished by deep industry and government experience, provides companies, academic and research institutions, and investors in the life sciences ecosystem with integrated and industry-leading transactional, regulatory, intellectual property, and litigation counsel.
In June of 2025, Crowell & Moring LLP and Faber Daeufer & Itrato PC combined to establish Crowell Life Sciences. Crowell Life Sciences brings together Faber’s leading life sciences-focused corporate, R&D transactional, and complex licensing and collaborations practice, with Crowell’s strengths in corporate, M&A, and capital markets, government investigations, commercial litigation, health care regulatory, patent prosecution, government contracting, international trade, data privacy, and IP litigation, positioning the team to provide global solution-oriented guidance in a dynamic business environment.
Crowell is an AmLaw 100 law firm with operations in the U.S., Europe, MENA, and Asia, including offices in Boston, San Francisco, Washington, D.C., New York, Chicago, London, and other centers of industry and finance. Drawing on significant industry, government, and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex transactional, regulatory, and litigation issues.
Crowell Life Sciences is a team of former biotech in-house counsel and business leaders, venture capital professionals, and pharmaceutical contract specialists. The team delivers pragmatic counsel to companies from start-up through commercialization, as well as to investment firms, universities, and nonprofits involved in the research, development, manufacture, and commercialization of novel therapeutics, diagnostics, medical devices, artificial intelligence, and digital health products. One of the largest teams supporting the life sciences sector, Crowell Life Sciences has represented more than 2,500 life sciences clients and, having lived clients’ challenges firsthand as in-house counsel, is well-versed in the complex business, intellectual property, and regulatory issues they face.
Gateway serves the residents and businesses of the greater New Haven region with innovative educational programming. Each year, more than 14,000 individuals choose from over 90 academic programs, which they take for college credit, professional development and personal enrichment. Gateway awards associate degrees and certificates in academic programs that transfer to four-year universities, along with career-track programs in engineering and automotive technologies, technical studies, health care, and business. Its location in downtown New Haven provides students with a myriad of social and cultural opportunities.
BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. We operate at the interface between academia and industry, performing biomedical research, drug discovery & development in the fields of oncology, immunology, neuroscience, women’s health, cardiometabolic diseases, platform technologies, and artificial intelligence.
All our research projects are sponsored by leading pharmaceutical companies and conducted by early-career scientists recruited from the best schools around the world. The combination of global crowdsourcing with local incubation of the best research talents and ideas allows us to solve the biggest challenges in biomedical research.
We stand for free, creative, and curiosity-driven research combined with a solid validation of results, timelines, and deliverables. We serve a large purpose in advancing translational biomedicine by leveraging synergies and fostering cross-pollination across disciplines.
Research Activities:
Lab Vendor is a cGMP-compliant biorepository facility specializing in secure, regulated storage of biological samples. We offer short-term and long-term sample storage with comprehensive sample, data, and location management in a controlled environment ranging from ambient to -196°C. In addition to biobanking services, we are authorized distributors of laboratory cold storage equipment, including freezers, refrigerators, and cryogenic storage solutions, with both purchase and rental options available. Lab Vendor also provides quality assurance and control, along with preventive maintenance and repair services, ensuring reliable sample preservation and optimal equipment performance for life sciences organizations.
OEM Group is a life science focused advertising agency. We specialize in:
New Product Launch Plans
OEM Group specializes in creating high-quality, impactful brands with a focus on omnichannel enablement and go-to-market acceleration. We:
Early-stage commercial life science and biotech
We provide corporate strategy, identity and MOA/MOD story telling for startup and early-stage life science and biotech.
Biological Relocation Solutions (BioRelo) is a nationwide laboratory moving company specializing in the safe and secure transport of biological material, laboratory chemicals, lab animals, and cryogenic storage systems. Whether moving across the hall, across town, or across the country, we handle every relocation with precision. With state-of-the-art trucks equipped with 24/7 temperature monitoring, we ensure your samples and assets arrive on time and at the correct temperature.
We proudly serve biotech, pharmaceutical, clinical, research, and academic institutions nationwide. From strategic planning to transport and final delivery, our project management team oversees every detail to guarantee a seamless relocation experience.
Revalia Bio Inc. is launching a new category of pre-clinical research that gives drug developers early, predictive insights from real, functional human organs called ‘Human Data Trials’.
Despite billions spent on R&D each year, more than 90 percent of drug candidates fail to reach market approval. One of the key reasons is the poor translation from preclinical models to human biology. Animal models and in vitro systems often fall short in predicting how therapies will behave in real patients, leading to delays, cost overruns, and failed trials. Revalia is addressing this breakdown by delivering on-demand access to functional human data through its Human Data Trials — rigorous testing conducted on perfused, human organs maintained under clinical conditions.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.